["{\n\"step_by_step_thinking\": \"The major aim of phase 1 clinical trials is to evaluate the safety of a new chemoprevention agent. According to 'The clinical evaluation of cancer chemoprevention agents: defining and contrasting phase I, II, and III objectives', the unique nature of the target populations, the scope of side effect evaluation, and the potential duration of treatment must be considered in the design of these trials.\",\n\"answer_choice\": \"A\"\n}"]